Topiramate induced acute angle closure glaucoma
- PMID: 19478906
- PMCID: PMC2687928
- DOI: 10.2174/1874364100802010046
Topiramate induced acute angle closure glaucoma
Abstract
Topiramate is an oral sulphamate medication primarily used for seizure, migraine and neuropathic pain. It has been associated with secondary angle closure, which can mimic acute angle closure glaucoma. Suspicion for medication induced angle closure glaucoma should be higher whenever angle closure presents bilaterally. We present two cases of bilateral angle closure glaucoma secondary to topiramate.
References
-
- Lachkar Y, Bouassida W. Drug induced angle closure glaucoma. Curr Opin Ophthalmol. 2007;18(2):129–133. - PubMed
-
- Banta JT, Hoffman K, Budenz DL, Ceballos E, Greenfield DS. Presumed topiramate induced bilateral acute angle closure glaucoma. Am J Ophthalmol. 2001;132:112–114. - PubMed
-
- Fraunfelder FW, Fraunfelder FT, Keates EU. Topiramate associated acute, bilateral, secondary angle closure glaucoma. Ophthalmology. 2004;111:109–111. - PubMed
-
- Quigly HA, Friedman DS, Congdon NG. Possible mechanisms of primary angle-closure and malignant glaucoma. J Glaucoma. 2003;12:167–180. - PubMed
-
- Banta JT, Hoffman K, Budenz DL, Ceballos E, Greenfield DS. Presumed topiramate induced bilateral acute angle closure glaucoma. Am J Ophthalmol. 2001;132:112–114. - PubMed
LinkOut - more resources
Full Text Sources